NOVAVAX Reports Progress Under Joint Venture in India With Cadila Pharmaceuticals
03 janv. 2012 08h00 HE
|
Novavax, Inc.
Regulatory approval received for rabies vaccine toxicology studies in India
Clinical study of influenza vaccine candidate planned for 2012
Validated manufacturing facility ready for...
NOVAVAX to Present at 23rd Annual Piper Jaffray Health Care Conference
28 nov. 2011 12h17 HE
|
Novavax, Inc.
ROCKVILLE, Md., Nov. 28, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
NOVAVAX Acquires New Manufacturing and Office Facilities in Gaithersburg, MD
21 nov. 2011 20h03 HE
|
Novavax, Inc.
ROCKVILLE, Md., Nov. 21, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has entered a long-term lease arrangement for 74,000-square-feet of manufacturing, lab and office...
NOVAVAX to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
10 nov. 2011 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., Nov. 10, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Frederick W. Driscoll, Vice President and Chief Financial Officer...
NOVAVAX Appoints Russell "Rip" Wilson Senior Vice President of Business Development
07 nov. 2011 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Russell P. "Rip" Wilson as Senior Vice President of Business Development. Mr. Wilson...
NOVAVAX Reports Third Quarter 2011 Financial Results
04 nov. 2011 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., Nov. 4, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the third quarter ended September 30, 2011.
Novavax reported a net loss of $3.2...
NOVAVAX Appoints Erica S. Shane, Ph.D., Vice President, Process Development
03 nov. 2011 16h28 HE
|
Novavax, Inc.
ROCKVILLE, Md., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Erica Shane, Ph.D., to the position of Vice President, Process Development. In this...
NOVAVAX to Report Third Quarter 2011 Financial Results on November 4, 2011
28 oct. 2011 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., Oct. 28, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) will report financial results for the third fiscal quarter of 2011 on Friday, November 4, 2011, before the U.S. financial...
NOVAVAX CEO Addresses U.S. Patent and Trademark Office (USPTO) on Behalf of the Biotechnology Industry Organization (BIO)
27 oct. 2011 14h27 HE
|
Novavax, Inc.
ROCKVILLE, Md., Oct. 27, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that Stanley C. Erck, President and Chief Executive Officer of Novavax, testified this afternoon on behalf...
NOVAVAX Announces Conference Call to Discuss Results From Phase I Trial of Respiratory Syncytial Virus Vaccine Candidate
10 oct. 2011 09h56 HE
|
Novavax, Inc.
ROCKVILLE, Md., Oct. 10, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will conduct a conference call for invited analysts and institutional investors on October 13,...